NEXIMMUNE INC (NEXI)

US65344D2080 - Common Stock

3.32  +0.2 (+6.41%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
44.86M63.08M53.25M27.85M20.89M
Research and Development
30.63M46.77M37.15M17.57M14.90M
Selling, General, and Administrative Expenses
14.21M16.31M16.10M10.28M5.98M
Operating Income
-44.86M-63.08M-53.25M-27.85M-20.89M
Interest Income/Expense
964.90K660.00K1.57M-2.10M250.00K
Other Income/Expense
-3.32K-90.00K-60.00K90.00K90.00K
Non Recurring Items
N/A0.00840.00KN/AN/A
Income Before Taxes
-43.88M-62.51M-50.90M-29.87M-20.55M
Net Income
-43.88M-62.51M-51.28M-33.15M-23.21M
EBITDA
-43.80M-62.09M-52.38M-27.23M-20.45M
 
Per Share Data
EPS Diluted Total Ops
-42.11-65.11-63.30-38.54-26.98
Non GAAP EPS
N/A-66.25-19.15N/AN/A
 
Statistics

All data in USD

Charts